$MLRT
Metalert, Inc. Stock $mlrt

$mlrt Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000149315222009687 Filed on April 12, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$47.76K	$589.4K	$128.2K
YoY Change	-62.74%	-44.35%	-40.59%
Cost Of Revenue	$70.58K	$334.2K	$128.2K
YoY Change	-44.94%	-44.21%	147.26%
Gross Profit	-$22.82K	$255.3K	$0.00
YoY Change		-44.55%	-100.0%
Gross Profit Margin	-47.78%	43.3%	0.0%
Selling, General & Admin	$268.0K	$320.6K	$269.2K
YoY Change	-0.44%	50.24%	511.06%
% of Gross Profit		125.61%
Research & Development		$1.282K
YoY Change		-90.6%
% of Gross Profit		0.5%
Depreciation & Amortization	$8.340K	$15.44K	$6.190K
YoY Change	34.73%	46.67%	9.36%
% of Gross Profit		6.05%
Operating Expenses	$276.3K	$1.160M	$269.2K
YoY Change	2.66%	6.65%	511.19%
Operating Profit	-$299.1K	-$904.5K	-$269.2K
YoY Change	11.13%	44.22%	-324.57%
Interest Expense	-$26.20K	-$112.8K	-$39.78K
YoY Change	-34.14%	-146.75%	-86.86%
% of Operating Profit
Other Income/Expense, Net	-$183.1K	-$295.9K	$18.99K
YoY Change	-1064.24%	-214.34%	68.8%
Pretax Income	-$442.4K	-$1.200M	-$401.7K
YoY Change	10.14%	225.85%	178.66%
Income Tax
% Of Pretax Income
Net Earnings	-$442.4K	-$1.200M	-$401.7K
YoY Change	10.14%	225.85%	178.66%
Net Earnings / Revenue	-926.32%	-203.66%	-313.38%
Basic Earnings Per Share		-$0.66
Diluted Earnings Per Share	-$2.000K	-$5.962K	-$2.973K
COMMON SHARES
Basic Shares Outstanding	225.0M shares	2.840M shares	135.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$140.8K	$140.8K	$81.08K
YoY Change	73.67%	73.67%	-56.04%
Cash & Equivalents	$138.3K	$138.3K	$76.91K
Short-Term Investments	$2.470K	$2.470K	$4.166K
Other Short-Term Assets	$55.02K	$55.02K	$54.59K
YoY Change	0.77%	0.79%	425.79%
Inventory	$98.26K	$98.26K	$114.1K
Prepaid Expenses
Receivables	$13.74K	$13.74K	$40.48K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$307.8K	$307.8K	$290.3K
YoY Change	6.04%	6.04%	4.12%
LONG-TERM ASSETS
Property, Plant & Equipment	$92.46K	$92.46K	$7.878K
YoY Change	1073.66%	1073.35%	-57.19%
Goodwill
YoY Change
Intangibles	$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$92.46K	$92.46K	$7.878K
YoY Change	1073.66%	1073.35%	-76.42%
TOTAL ASSETS
Total Short-Term Assets	$307.8K	$307.8K	$290.3K
Total Long-Term Assets	$92.46K	$92.46K	$7.878K
Total Assets	$400.3K	$400.3K	$298.2K
YoY Change	34.24%	34.25%	-4.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$182.6K	$156.9K	$182.6K
YoY Change	0.0%	-14.08%	-10.1%
Accrued Expenses	$327.3K	$1.086M	$327.3K
YoY Change	0.0%	-6.97%	-25.8%
Deferred Revenue	$37.35K		$37.35K
YoY Change	0.0%		-46.7%
Short-Term Debt		$1.775M	$400.00
YoY Change		-0.02%	-99.81%
Long-Term Debt Due	$81.95K	$81.95K	$21.72K
YoY Change	277.3%	277.3%
Total Short-Term Liabilities	$3.137M	$3.137M	$3.184M
YoY Change	-1.49%	-1.49%	-18.55%
LONG-TERM LIABILITIES
Long-Term Debt	$142.9K	$142.9K	$217.9K
YoY Change	-34.4%	-34.4%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$142.9K	$142.9K	$217.9K
YoY Change	-34.4%	-34.4%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.137M	$3.137M	$3.184M
Total Long-Term Liabilities	$142.9K	$142.9K	$217.9K
Total Liabilities	$3.280M	$3.280M	$3.402M
YoY Change	-3.6%	-3.6%	-12.98%
SHAREHOLDERS EQUITY
Retained Earnings	-$26.05M		-$24.18M
YoY Change	7.76%		2.62%
Common Stock	$22.45K		$13.80K
YoY Change	62.65%		93.27%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.880M	-$2.880M	-$3.104M
YoY Change
Total Liabilities & Shareholders Equity	$400.3K	$400.3K	$298.2K
YoY Change	34.24%	34.25%	-4.5%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$442.4K	-$1.200M	-$401.7K
YoY Change	10.14%	225.85%	178.66%
Depreciation, Depletion And Amortization	$8.340K	$15.44K	$6.190K
YoY Change	34.73%	46.67%	9.36%
Cash From Operating Activities	-$119.7K	-$497.7K	-$140.5K
YoY Change	-14.86%	-10.58%	30.08%
INVESTING ACTIVITIES
Capital Expenditures	-$35.52K	$100.0K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$1.260K	$0.00
YoY Change		-99.14%	-100.0%
Cash From Investing Activities	-$35.52K	-$98.76K	$0.00
YoY Change		-167.55%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	$657.9K	-9.970K
YoY Change	-100.0%	81.7%	-108.73%
NET CHANGE
Cash From Operating Activities	-119.7K	-$497.7K	-140.5K
Cash From Investing Activities	-35.52K	-$98.76K	0.000
Cash From Financing Activities	0.000	$657.9K	-9.970K
Net Change In Cash	-155.2K	$61.43K	-150.5K
YoY Change	3.1%	-227.22%	-407.23%
FREE CASH FLOW
Cash From Operating Activities	-$119.7K	-$497.7K	-$140.5K
Capital Expenditures	-$35.52K	$100.0K
Free Cash Flow	-$84.13K	-$597.7K
YoY Change		7.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001375793
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings		usd
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	GTXO	Gain On Forgiveness Of Accrued Interest GainOnForgivenessOfAccruedInterest		usd
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2020	GTXO	Loss On Conversion Of Debt LossOnConversionOfDebt		usd
CY2021	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends		usd
CY2020	GTXO	Deemed Dividend DeemedDividend		usd
CY2021	GTXO	Proceeds From Issuance Of Preferred Stock For Financing ProceedsFromIssuanceOfPreferredStockForFinancing		usd
CY2021	GTXO	Issuance Of Common Stock For Conversion Of Warrants IssuanceOfCommonStockForConversionOfWarrants		usd
CY2021	GTXO	Issuance Of Common Stock For Preferred Shares IssuanceOfCommonStockForPreferredShares		usd
CY2021	GTXO	Deemed Dividend DeemedDividend		usd
CY2021	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2020	GTXO	Adjustments For Bonus Shares Issued To Noteholders AdjustmentsForBonusSharesIssuedToNoteholders		usd
CY2020	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty		usd
CY2020	GTXO	Interest Added To Convertible Note Balance InterestAddedToConvertibleNoteBalance		usd
CY2021	GTXO	Debt Discount On Notes Payable Related Parties DebtDiscountOnNotesPayableRelatedParties		usd
CY2020	GTXO	Debt Discount On Notes Payable Related Parties DebtDiscountOnNotesPayableRelatedParties		usd
CY2021	GTXO	Grant From Care Loans GrantFromCareLoans		usd
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt		usd
CY2021	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2020	GTXO	Noncash Debt Discount On Notes Convertible NoncashDebtDiscountOnNotesConvertible		usd
CY2020	GTXO	Transfer Of Convertible Related Party Debt TransferOfConvertibleRelatedPartyDebt		usd
CY2020	GTXO	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock		usd
CY2020	GTXO	Noncash Conversion Of Accrued Interest NoncashConversionOfAccruedInterest		usd
CY2020	GTXO	Related Party Accrued Expenses To Convertible Debt Related Party RelatedPartyAccruedExpensesToConvertibleDebtRelatedParty		usd
CY2021Q4	us-gaap	Short Term Borrowings ShortTermBorrowings		usd
CY2021Q4	GTXO	Line Of Credit One LineOfCreditOne		usd
CY2020Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings		usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent		usd
CY2020Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2020	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	000-53046
CY2021	dei	Entity Registrant Name EntityRegistrantName	GTX Corp
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-0493446
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	117 W 9th Street
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 1214
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Los Angeles
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90015
CY2021	dei	City Area Code CityAreaCode	213
CY2021	dei	Local Phone Number LocalPhoneNumber	489-3019
CY2021	dei	Security12b Title Security12bTitle	None
CY2021	dei	Trading Symbol TradingSymbol	GTXO
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	true
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	14852	usd
CY2022Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	228502479	shares
CY2021	dei	Auditor Name AuditorName	M&K CPAS, PLLC
CY2021	dei	Auditor Location AuditorLocation	Houston, Texas
CY2021	dei	Auditor Firm AuditorFirmId	2738
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	138342	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76912	usd
CY2021Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	13735	usd
CY2020Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	40484	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	114137	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2465	usd
CY2020Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4166	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	55016	usd
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	54593	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	307816	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	290292	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7878	usd
CY2021Q4	us-gaap	Assets Assets	400277	usd
CY2020Q4	us-gaap	Assets Assets	298170	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	156886	usd
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	182610	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	298662	usd
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	327293	usd
CY2021Q4	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	787044	usd
CY2020Q4	GTXO	Accrued Expenses Related Parties Current AccruedExpensesRelatedPartiesCurrent	839810	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37250	usd
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37350	usd
CY2021Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	7000	usd
CY2020Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	21715	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	758000	usd
CY2020Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	840673	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	976546	usd
CY2020Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	884546	usd
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	40640	usd
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	50400	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3136981	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3184397	usd
CY2021Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	142917	usd
CY2020Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	217870	usd
CY2021Q4	us-gaap	Liabilities Liabilities	3279898	usd
CY2020Q4	us-gaap	Liabilities Liabilities	3402267	usd
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2071000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	224502479	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	224502479	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	138032482	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	138032482	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	22450	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	13803	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23151212	usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	21059925	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24177926	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3104097	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	400277	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	298170	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1059270	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	334186	usd
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	598963	usd
CY2021	us-gaap	Gross Profit GrossProfit	255254	usd
CY2020	us-gaap	Gross Profit GrossProfit	460307	usd
CY2021	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	501544	usd
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	621347	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	337627	usd
CY2020	us-gaap	Professional Fees ProfessionalFees	252765	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	75391	usd
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	28091	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	245238	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	185316	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1159800	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	1087519	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-904546	usd
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-627212	usd
CY2020	GTXO	Gain On Forgiveness Of Accrued Interest GainOnForgivenessOfAccruedInterest	17531	usd
CY2021	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	-443	usd
CY2020	GTXO	Gain Loss On Marketable Securities GainLossOnMarketableSecurities	91143	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	30705	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	223536	usd
CY2021	GTXO	Loss On Conversion Of Debt LossOnConversionOfDebt	-152406	usd
CY2021	GTXO	Interest Expense And Financing Costs InterestExpenseAndFinancingCosts	112358	usd
CY2020	GTXO	Interest Expense And Financing Costs InterestExpenseAndFinancingCosts	73405	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-295912	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	258805	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-368407	usd
CY2020	us-gaap	Redeemable Preferred Stock Dividends RedeemablePreferredStockDividends	100000	usd
CY2021	GTXO	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	675000	usd
CY2020	GTXO	Redeemable Preferred Stock Dividends One RedeemablePreferredStockDividendsOne	150000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1875458	usd
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-618407	usd
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	201353941	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	109772603	shares
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.01
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.00
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-3597538	usd
CY2020	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	171583	usd
CY2020	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	403824	usd
CY2020	GTXO	Issuance Of Preferred Stock For Financing IssuanceOfPreferredStockForFinancing	250000	usd
CY2020	GTXO	Adjustments To Additional Paid In Fair Value Of Warrants Issued For Services AdjustmentsToAdditionalPaidInFairValueOfWarrantsIssuedForServices	3793	usd
CY2020	GTXO	Fair Value Of Common Stock Issued To Management FairValueOfCommonStockIssuedToManagement	-4461	usd
CY2020	GTXO	Issuance Of Preferred Stock IssuanceOfPreferredStock	150000	usd
CY2020	GTXO	Adjustments To Additional Paid In Capital Gains From Forgiveness Of Debt Related Party. AdjustmentsToAdditionalPaidInCapitalGainsFromForgivenessOfDebtRelatedParty.	32648	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-368407	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-3104097	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	263135	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	194373	usd
CY2021	GTXO	Stock Issuance Of Common Stock For Financings StockIssuanceOfCommonStockForFinancings	3275	usd
CY2021	GTXO	Warrants Issued For Services WarrantsIssuedForServices	2340	usd
CY2021	GTXO	Shares Issued For Conversion Of Debt SharesIssuedForConversionOfDebt	218106	usd
CY2021	GTXO	Imputted Interest ImputtedInterest	30705	usd
CY2021	GTXO	Additional Paid In Capital Debt Discount AdditionalPaidInCapitalDebtDiscount	38000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-368407	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	15438	usd
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25526	usd
CY2021	GTXO	Bad Debt Expense BadDebtExpense	28323	usd
CY2020	GTXO	Bad Debt Expense BadDebtExpense	11572	usd
CY2021	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	-443	usd
CY2020	us-gaap	Marketable Securities Gain Loss MarketableSecuritiesGainLoss	91142	usd
CY2021	GTXO	Fair Value Of Common Stock Issued For Services FairValueOfCommonStockIssuedForServices	263135	usd
CY2020	GTXO	Fair Value Of Common Stock Issued For Services FairValueOfCommonStockIssuedForServices	171583	usd
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	223536	usd
CY2021	GTXO	Adjustments For Bonus Shares Issued To Noteholders AdjustmentsForBonusSharesIssuedToNoteholders	3275	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-152406	usd
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	17531	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	2340	usd
CY2020	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	3793	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	30705	usd
CY2021	GTXO	Interest Added To Convertible Note Balance InterestAddedToConvertibleNoteBalance	102040	usd
CY2020	GTXO	Grant From Care Loans GrantFromCareLoans	10000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1574	usd
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4238	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15879	usd
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	77946	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	328	usd
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	44210	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	95	usd
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	20516	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-43022	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-71122	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	133909	usd
CY2020	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	192340	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-100	usd
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-32722	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-497684	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-556556	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	1258	usd
CY2020	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	146200	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	100021	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98763	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	146200	usd
CY2020	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	227870	usd
CY2021	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	675000	usd
CY2020	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	250000	usd
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	139319	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2123	usd
CY2020	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	39517	usd
CY2021	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	15000	usd
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	215604	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1059270	usd
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	589440	usd
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1059270	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	657877	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	362068	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	61430	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	40351	usd
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	21126	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-48288	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125200	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	138342	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	76912	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	623	usd
CY2020	us-gaap	Interest Paid Net InterestPaidNet	11199	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	149373	usd
CY2020	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	253355	usd
CY2021	GTXO	Noncash Debt Discount On Notes Convertible NoncashDebtDiscountOnNotesConvertible	38000	usd
CY2021	GTXO	Transfer Of Convertible Related Party Debt TransferOfConvertibleRelatedPartyDebt	70000	usd
CY2021	GTXO	Conversion Of Preferred Stock To Common Stock ConversionOfPreferredStockToCommonStock	3800	usd
CY2021	GTXO	Deemed Dividends DeemedDividends	675000	usd
CY2020	GTXO	Deemed Dividends DeemedDividends	250000	usd
CY2021	GTXO	Noncash Conversion Of Accrued Interest NoncashConversionOfAccruedInterest	109230	usd
CY2021	GTXO	Related Party Accrued Expenses To Convertible Debt Related Party RelatedPartyAccruedExpensesToConvertibleDebtRelatedParty	200000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1200458	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26053384	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-2879621	usd
CY2021	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company’s warranty policy provides repair or replacement of products (excluding GPS Shoe devices) returned for defects within ninety days of purchase
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zJ0Bb0BjRNvc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_861_zCXEzatI7Nv9">Use of Estimates</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory reserves and returns, impairment analysis of long-term assets and deferred tax assets, accruals for potential liabilities and assumptions made in valuing the fair market value of equity transactions. Estimates are updated on an ongoing basis and are evaluated based on historical experience and current circumstances. Changes in facts and circumstances in the future may give rise to changes in these estimates which may cause actual results to differ from current estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1282	usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	13643	usd
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84C_eus-gaap--ConcentrationRiskCreditRisk_zx05dJchF4dj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration: underline"><span id="xdx_86B_zrvtNHgWGIZi">Concentrations</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We currently rely on one manufacturer to supply us with our GPS SmartSole and one manufacturer to supply us with the GPS device included in the GPS SmartSole. The loss of either of these manufacturers could severely impede our ability to manufacture the GPS SmartSole.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company had three customers representing approximately <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zup2l9MBFTeg" title="Concentration risk, percentage">63</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zS26CJZfL672">11</span>% and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_zqO0TmXLIRE2">10</span>% of sales and four customers representing approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zTg3KxILTdtf">26</span>%, <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zLOpDviDfBP7">12</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6WEXjfZRckb">12</span>% and <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zC4nqfbVqj49">10</span>% of total accounts receivable, respectively. The Company had three customers representing approximately <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z4DYndWc1UJi">18</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zz3xWC2TNLrb">9</span>% and <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__srt--MajorCustomersAxis__custom--CustomerThreeMember_z2NA7WgxJdcg">7</span>% of sales and four customers representing approximately <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_zm1EFGFBlbK3">13</span>%, <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerTwoMember_zQ6eTpC7pHA3">13</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_dp_uPure_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_ztFbfJriNko4">13</span>% and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerFourMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z0LfwOS4LhJd">11</span>% of total accounts receivable, respectively, for the year ended December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	188841667	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	206253481	shares
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	integer
CY2021	GTXO	Investment Owned Description InvestmentOwnedDescription	The Company’s investments in marketable securities is comprised of shares of stock of two (2) entities with ownership percentages of less than 5%. The Company accounted for these investments pursuant to ASU 320, Investments – Debt and Equity Securities. As such, these investments were recorded at their market value as of December 31, 2019, with the change in fair value being reflected in the statement of operations.
CY2019	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	10889	shares
CY2020	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	8500	shares
CY2021Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	71936	usd
CY2020Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	9	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	25322	usd
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	114128	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	98258	usd
CY2020Q4	us-gaap	Inventory Net InventoryNet	114137	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	421573	usd
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	406135	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	92461	usd
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7878	usd
CY2021	us-gaap	Depreciation Depreciation	15438	usd
CY2020	us-gaap	Depreciation Depreciation	10526	usd
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	400	usd
CY2021Q4	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	40640	usd
CY2020Q4	GTXO	Short Term Borrowings One ShortTermBorrowingsOne	50000	usd
CY2021Q4	us-gaap	Line Of Credit LineOfCredit	7000	usd
CY2020Q4	us-gaap	Line Of Credit LineOfCredit	22000	usd
CY2020Q4	GTXO	Line Of Credit One LineOfCreditOne	-285	usd
CY2021Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	74953	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	122593	usd
CY2020Q4	us-gaap	Notes Payable NotesPayable	72115	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	840673	usd
CY2021Q4	GTXO	Convertible Notes Payable Gross ConvertibleNotesPayableGross	758000	usd
CY2020Q4	GTXO	Convertible Notes Payable Gross ConvertibleNotesPayableGross	840673	usd
CY2021Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	758000	usd
CY2020Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	840673	usd
CY2021Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2020Q4	GTXO	Paycheck Protection Program Loan Amount PaycheckProtectionProgramLoanAmount	67870	usd
CY2021Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	7083	usd
CY2021Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	142917	usd
CY2020Q4	us-gaap	Other Loans Payable Long Term OtherLoansPayableLongTerm	150000	usd
CY2021Q4	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2020Q4	GTXO	Short Term And Long Term Loans Payable ShortTermAndLongTermLoansPayable	217870	usd
CY2020Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	884546	usd
CY2020	GTXO	Donation Amount DonationAmount	46000	usd
CY2020	GTXO	Donation Amount DonationAmount	46000	usd
CY2020	GTXO	Direct Contribution From Management Team DirectContributionFromManagementTeam	33000	usd
CY2020Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	0	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	470375	usd
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	104658	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	167625	usd
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	20342	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-73000	usd
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-60000	usd
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2408000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-2192000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1843000	usd
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2127000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3891095	usd
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3541782	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3891095	usd
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3541782	usd
CY2021Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	18524289	usd
CY2021	GTXO	Income Tax Expiration IncomeTaxExpiration	2028
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	460783	usd
CY2021	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	86469997	shares
CY2020	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	608955	usd
CY2020	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	66612687	shares
CY2021	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-75 reverse stock split
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	36000000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	20250000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	5750000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	50500000	shares
CY2021	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	0.0025
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	23500000	shares
CY2021	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	0.04
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	22500000	shares
CY2021	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpiredInPeriodWeightedAverageExercisePrice	0.01
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	250000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	49250000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	5750000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	20250000	shares
CY2020	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisable	50500000	shares
CY2020Q4	GTXO	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	250000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	22500000	shares
CY2021	GTXO	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding And Exercisable ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingAndExercisable	49250000	shares
CY2021Q4	GTXO	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableIntrinsicValue1	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2021Q4	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd
CY2020Q4	GTXO	Bonus Declared Or Accrued BonusDeclaredOrAccrued	0	usd

Files In Submission

Name	View Source	Status
0001493152-22-009687-index-headers.html	Edgar Link	pending
0001493152-22-009687-index.html	Edgar Link	pending
0001493152-22-009687.txt	Edgar Link	pending
0001493152-22-009687-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
gtxo-20211231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
gtxo-20211231_cal.xml	Edgar Link	unprocessable
gtxo-20211231_def.xml	Edgar Link	unprocessable
gtxo-20211231_lab.xml	Edgar Link	unprocessable
gtxo-20211231_pre.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLRT
Metalert, Inc. Stock $mlrt

2021 Q4 Form 10-K Financial Statement

#000149315222009687 Filed on April 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT Metalert, Inc. Stock $mlrt

2021 Q4 Form 10-K Financial Statement

#000149315222009687 Filed on April 12, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLRT
Metalert, Inc. Stock $mlrt